Clinical Trial

Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research

Study acronym: ALD Biobank
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-14
notable Primary completion pushed: 2026-06-01 -> 2026-12-01 2026-08-14
minor Completion pushed: 2026-12-01 -> 2027-01-01 2026-08-14
Trial Details
NCT Number NCT04664192
Lead Sponsor Baylor Research Institute
Conditions Respiratory Failure, Interstitial Lung Disease, Lung Diseases
Enrollment 100 participants
Start Date 2021-06-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13